Description
Individual Screening
Directions
Review the clinician provider guidelines and recommendations found at:
Agency for Healthcare Research and Quality [AHRQ]. (2014). Guide to clinical preventive services. Retrieved from: https://www.ahrq.gov/professionals/clinicians-prov...
and also at:
The guide to clinical preventive services. (2014, May). Recommendations of the U.S. preventive services task force. Retrieved from https://www.ahrq.gov/sites/default/files/wysiwyg/p...
For the MSN prepared nurse, knowledge of epidemiology and its application to preventive screening guidelines is important in many clinical areas; administrative, informatics, education and nurse practitioner fields. Consider you are working in a clinic and need to order a preventive screening on a patient for one of the conditions listed below. (While this is a preventative measure, it also can be a diagnostic tool in other circumstances. For this Assignment the screening is a secondary prevention measure.)
Please select one screening. Your screening methodology must come from the National Clearinghouse guidelines.
- Abdominal Aortic Aneurysm
- Breast Cancer
- Cervical Cancer
- Colon Cancer
- Diabetes Mellitus II
- Lung Cancer
Explain the guideline, the correct application of the screening, and the epidemiology behind the guidance. Content required should include epidemiologic data such as statistical information as available ex. morbidity, mortality, incidence and prevalence of condition. Identify risk factors, risk assessment, testing interval, description of the patient population, screening test recommendations and other factors relative to the guideline.
This paper should be 2–3 pages, excluding your title page, and references. This paper should adhere to appropriate 6th edition APA format.
Unformatted Attachment Preview
Purchase answer to see full attachment
Explanation & Answer
Attached.
Diabetes Mellitus Screening - Outline
Thesis Statement: The proper screening of Diabetes Mellitus is necessary for the close
monitoring and control of the condition. The appropriate screening for type 2 diabetes is by the
FPG test.
I. Introduction
II. The screening test
A. Screening tests available
B. The fasting plasma glucose(FPG)
III. Epidemiological data
A. Morbidity
B. Mortality
C. Incidence
D. Prevalence
IV. Risk factors
V. Recommendations
A. Risk assessment
B. Screening interval
C. Patient population
D. Healthy living
VI. Conclusion
Running head: DIABETES MELLITUS SCREENING
Diabetes Mellitus Screening
Name
Institution
1
DIABETES MELLITUS SCREENING
2
Diabetes Mellitus Screening
Diabetes is a condition that is caused by the defects in the secretion of insulin, insulin
action in the body or a combination of both. The lifelong condition results in hyperglycemia.
Chronic hyperglycemia can lead to damage and failure of organs such as kidneys, eyes, heart,
and blood vessels. There are two types of diabetes; Type 1 and Type 2. The first type is caused
by beta-cell destruction which leads to absolute insulin deficiency. Type two diabetes is
characterized by either effective insulin resistance or an insulin secretory defect. While both
types exist, Type two diabetes accounts for approximately 90-05% of the cases of diabetes. The
proper screening of Diabetes Mellitus is necessary for the close monitoring and control of the
condition. The appropriate screening for type 2 diabetes is by the FPG test.
The diagnosis of diabetes has, for a long time, relied on the observation of glucose. The
FPG or the 75-g OGTT was applied. The criteria were, however, revised by an expert committee
in 1...